Skip directly to site content Skip directly to search


Español  Other Languages


Centers for Disease Control and Prevention. CDC twenty four seven. Saving Lives, Protecting People
 ×
				Submit


Vital Signs


Section Navigation
			
			CDC Home








View All Topics
 View All Topics


Related Pages
										Updated Feb. 6, 2023 | Print33%Black people make up 33% of all U.S. patients receiving dialysis, but only 12% of the overall U.S. population.100xAdults on dialysis were 100 times more likely to have a staph bloodstream infection than adults not on dialysis during 2017–2020.40%Hispanic patients on dialysis had 40% higher risk of staph bloodstream infections than White patients on dialysis during 2017–2020.Overview
More than 800,000 people in the U.S. live with end-stage kidney disease, and more than half of them belong to a racial or ethnic minority group. High blood pressure and diabetes are medical conditions that increase a person’s risk of developing end-stage kidney disease. Some people with end-stage kidney disease have a kidney transplant, but most receive dialysis treatments (a process of filtering and removing waste products and excess fluid from the body).
Dialysis treatment puts patients at higher risk for serious infections because it requires frequent access to the bloodstream using needles or catheters (soft plastic tubes inserted into large veins). If germs get into a patient’s blood, they can cause serious infections that may lead to sepsis (a potentially life-threatening immune system response) and even death. Many germs can cause dialysis bloodstream infections. The most common is a group of germs called *Staphylococcus aureus* (staph). Staph infections can be difficult to treat and may be deadly.
More than 14,000 bloodstream infections occurred in patients on dialysis in the U.S. in 2020, and more than one in three were caused by staph. The risk for staph bloodstream infection is strongly affected by how a person’s blood circulation is connected to the dialysis machine, known as vascular access type. Staph bloodstream infections happen more often in Black and Hispanic patients on dialysis than White patients on dialysis, although other factors besides race and ethnicity may be involved. There are more staph bloodstream infections in areas of the U.S. with higher poverty, more household crowding, and lower education levels (from U.S. census data).
The good news is that bloodstream infections in patients on dialysis have gone down since 2014 with the widespread use of proven practices to prevent and control infections. Preventing infections among patients receiving dialysis requires a broad and equitable approach to prevention and care of kidney disease for people from all racial, ethnic, and socioeconomic* groups, including:
Encouraging practices that are known to prevent and slow the progression of chronic kidney disease.
Increasing the use of vascular access types that are proven to be lower risk for infections, such as fistulas and grafts, for people starting and currently on dialysis.
Continuing to apply proven practices to prevent and control infections in all U.S. dialysis facilities.*A way of describing people often based on their level of education, income, place of residence, and job type.Read the full *MMWR*ASL video: English | SpanishChallengesshield icon
People on dialysis are at risk for staph bloodstream infections, which can be serious or fatal.blue shapeAdvance Equityscales icon
Remove barriers to chronic kidney disease care for all people.blue shapePrevent Infectionshand holding lightbulb icon
Increase use of lower-risk vascular access types for dialysis, such as fistulas and grafts.blue shapeChallengesshield icon
People on dialysis are at risk for staph bloodstream infections, which can be serious or fatal.blue shapeAdvance Equityscales icon
Remove barriers to chronic kidney disease care for all people.blue shapePrevent Infectionshand holding lightbulb icon
Increase use of lower-risk vascular access types for dialysis, such as fistulas and grafts.blue shapeOverview
More than 800,000 people in the U.S. live with end-stage kidney disease, and more than half of them belong to a racial or ethnic minority group. High blood pressure and diabetes are medical conditions that increase a person’s risk of developing end-stage kidney disease. Some people with end-stage kidney disease have a kidney transplant, but most receive dialysis treatments (a process of filtering and removing waste products and excess fluid from the body).
Dialysis treatment puts patients at higher risk for serious infections because it requires frequent access to the bloodstream using needles or catheters (soft plastic tubes inserted into large veins). If germs get into a patient’s blood, they can cause serious infections that may lead to sepsis (a potentially life-threatening immune system response) and even death. Many germs can cause dialysis bloodstream infections. The most common is a group of germs called *Staphylococcus aureus* (staph). Staph infections can be difficult to treat and may be deadly.
More than 14,000 bloodstream infections occurred in patients on dialysis in the U.S. in 2020, and more than one in three were caused by staph. The risk for staph bloodstream infection is strongly affected by how a person’s blood circulation is connected to the dialysis machine, known as vascular access type. Staph bloodstream infections happen more often in Black and Hispanic patients on dialysis than White patients on dialysis, although other factors besides race and ethnicity may be involved. There are more staph bloodstream infections in areas of the U.S. with higher poverty, more household crowding, and lower education levels (from U.S. census data).
The good news is that bloodstream infections in patients on dialysis have gone down since 2014 with the widespread use of proven practices to prevent and control infections. Preventing infections among patients receiving dialysis requires a broad and equitable approach to prevention and care of kidney disease for people from all racial, ethnic, and socioeconomic* groups, including:
Encouraging practices that are known to prevent and slow the progression of chronic kidney disease.
Increasing the use of vascular access types that are proven to be lower risk for infections, such as fistulas and grafts, for people starting and currently on dialysis.
Continuing to apply proven practices to prevent and control infections in all U.S. dialysis facilities.*A way of describing people often based on their level of education, income, place of residence, and job type.Read the full *MMWR*ASL video: English | SpanishChallengeslarge shield icon
**High risk for infection:** Infections are common among patients on dialysis. These patients are more likely to get a staph bloodstream infection than people not on dialysis. Staph bloodstream infections can be serious or lead to death, and some infections are resistant to some of the most common antibiotics used to treat them, making the drugs ineffective.
**Racial and ethnic gaps:** End-stage kidney disease affects Black and Hispanic people more than White people. Black and Hispanic people have greater numbers of medical conditions, such as high blood pressure and diabetes, which increase their risk of developing end-stage kidney disease. There are also differences in the types of therapies and treatments that Black and Hispanic patients receive for end-stage kidney disease. In addition, more Black and Hispanic patients on dialysis get staph bloodstream infections than White patients on dialysis.
**Social and economic factors:** Lack of prevention and care of kidney disease, socioeconomic and insurance status, and lack of patient education about treatment options are all factors in end-stage kidney disease treatment differences.
**Catheter use:** Vascular access type is the major risk factor for bloodstream infections regardless of race, ethnicity, or socioeconomic status. There are three access types: fistula, graft, and central venous catheter. People with any access type can develop an infection, but fistulas have the lowest risk of infection and central venous catheters have the highest risk of infection.Adults on Dialysis Are More Likely to Have Staph Bloodstream Infections
Adults on dialysis are 100 times more likely to have a staph bloodstream infection than adults not on dialysis.
View Larger
Close
Infographic 1: Adults on Dialysis Are More Likely to Have Staph Bloodstream InfectionsRate per 100,000 people per year
Adults not on dialysis: 42
Adults on dialysis (100 times more likely to have a staph bloodstream infection): 4,248
Download Image[PNG]Inequities Can Lead to More Staph Bloodstream Infections
Race, ethnicity, and socioeconomic factors can lead to more dialysis bloodstream infections.
View Larger
Close
Infographic 2: Inequities Can Lead to More Staph Bloodstream InfectionsSocioeconomic Factors:
Poverty
Household Crowding
Limited Education
Staph Bloodstream Infection Rates by Race/Ethnicity*
Rate per 100,000 patients on dialysis per year
Black: 4,751
Hispanic: 4,500
White: 3,866
*2017–2020 Emerging Infections Program surveillance data
Download Image[PNG]Adults on Dialysis Are More Likely to Have Staph Bloodstream Infections
Adults on dialysis are 100 times more likely to have a staph bloodstream infection than adults not on dialysis.
View Larger
Close
Infographic 1: Adults on Dialysis Are More Likely to Have Staph Bloodstream InfectionsRate per 100,000 people per year
Adults not on dialysis: 42
Adults on dialysis (100 times more likely to have a staph bloodstream infection): 4,248
Download Image[PNG]
Inequities Can Lead to More Staph Bloodstream Infections
Race, ethnicity, and socioeconomic factors can lead to more dialysis bloodstream infections.
View Larger
Close
Infographic 2: Inequities Can Lead to More Staph Bloodstream InfectionsSocioeconomic Factors:
Poverty
Household Crowding
Limited Education
Staph Bloodstream Infection Rates by Race/Ethnicity*
Rate per 100,000 patients on dialysis per year
Black: 4,751
Hispanic: 4,500
White: 3,866
*2017–2020 Emerging Infections Program surveillance data
Download Image[PNG]Increase Use of Lower-Risk Vascular Access Types for Dialysis
Reducing the use of central venous catheters for people on dialysis can help prevent bloodstream infections.
View Larger
Close
Infographic 3: Increase Use of Lower-Risk Vascular Access Types for DialysisRisk of Bloodstream Infections
Low Risk: Fistula
Medium Risk: Graft
High Risk: Central Venous Catheter
Download Image[PNG]**What Can Be Done**To Advance Health EquityBloodstream infections are preventable in all patients on dialysis. Actions by healthcare providers, dialysis providers, dialysis partner organizations, and public health professionals can help prevent these infections. Extra attention should be focused on people from groups experiencing racial, ethnic, and socioeconomic differences in staph bloodstream infections. Actions include:
Promoting practices to prevent and manage chronic conditions like diabetes and high blood pressure and detecting and treating chronic kidney disease in its early stages to prevent the need for dialysis.
Counseling patients on potential treatment options, in their preferred language, before they develop end-stage kidney disease.
Coordinating efforts between patients, nephrologists, vascular access surgeons, radiologists, nurses, nurse practitioners, and social workers to reduce the use of central venous catheters for dialysis treatment.
Educating and empowering patients with culturally appropriate resources to help prevent infections and understand infection risks of different access types, especially central venous catheters.
Reducing barriers for patients receiving medical care by offering transportation assistance, insurance coverage expertise, social work services, and education resources in multiple languages.Better information can lead to more effective infection prevention programs and catheter reduction policies that will benefit everyone on dialysis. More data about dialysis bloodstream infections in patients of different races, ethnicities, and socioeconomic statuses can be gained by:
Improving monitoring for dialysis bloodstream infections that includes racial, ethnic, and socioeconomic factors, as well as patient vascular access types.
Doing more studies to better understand racial, ethnic, and socioeconomic differences and how these impact people on dialysis.Photo collage of kidneys, patient set up for dialysis, nurse asking a patient questions, and a trio of women jogging.Bloodstream infections are preventable in all patients on dialysis. Actions by healthcare providers, dialysis providers, dialysis partner organizations, and public health professionals can help prevent these infections. Extra attention should be focused on people from groups experiencing racial, ethnic, and socioeconomic differences in staph bloodstream infections. Actions include:
Promoting practices to prevent and manage chronic conditions like diabetes and high blood pressure and detecting and treating chronic kidney disease in its early stages to prevent the need for dialysis.
Counseling patients on potential treatment options, in their preferred language, before they develop end-stage kidney disease.
Coordinating efforts between patients, nephrologists, vascular access surgeons, radiologists, nurses, nurse practitioners, and social workers to reduce the use of central venous catheters for dialysis treatment.
Educating and empowering patients with culturally appropriate resources to help prevent infections and understand infection risks of different access types, especially central venous catheters.
Reducing barriers for patients receiving medical care by offering transportation assistance, insurance coverage expertise, social work services, and education resources in multiple languages.Better information can lead to more effective infection prevention programs and catheter reduction policies that will benefit everyone on dialysis. More data about dialysis bloodstream infections in patients of different races, ethnicities, and socioeconomic statuses can be gained by:
Improving monitoring for dialysis bloodstream infections that includes racial, ethnic, and socioeconomic factors, as well as patient vascular access types.
Doing more studies to better understand racial, ethnic, and socioeconomic differences and how these impact people on dialysis.
Photo collage of kidneys, patient set up for dialysis, nurse asking a patient questions, and a trio of women jogging.To Prevent Infections
**Healthcare providers can:**Use Proven Practices
Follow CDC’s approach to bloodstream infection prevention in dialysis facilities, which has been shown to help reduce infections.
Raise awareness and promote use of CDC audit tools and checklists for recommended infection prevention practices.
Act fast if you suspect sepsis. Know sepsis signs and symptoms to identify and treat patients early.Support Catheter Reduction
Educate patients and staff about end-stage kidney disease therapies, including kidney transplant and vascular access options for dialysis, with culturally appropriate materials in their preferred language. When appropriate, refer patients to vascular access surgeons and assess patients for transplant suitability.
Identify and address barriers to central venous catheter removal and placement of permanent vascular access types, such as fistulas and grafts.
Promote education and partnership initiatives like the Making Dialysis Safer for Patients Coalition and the End Stage Renal Disease Network Program.**Everyone can:**


Prevent chronic kidney disease by managing diabetes and high blood pressure. Learn about chronic kidney disease and its risk factors.
 	Read and share infection prevention resources for patients on dialysis.
 	Clean your hands often with alcohol-based hand sanitizer or soap and water to prevent the spread of germs.
 	Watch for signs of infection and its complications, like sepsis.Footnotes and References
	Footnote
*A way of describing people often based on their level of education, income, place of residence, and job type.
Related Pages and Resources
*Vital Signs:* Media Statement – Black and Hispanic Patients on Dialysis Have Higher Rates of Staph Bloodstream Infections [English]
*Vital Signs:* Media Statement – Los pacientes de raza negra e hispanos en diálisis tienen tasas más altas de infecciones del torrente sanguíneo por estafilococos [Spanish]
*Morbidity and Mortality Weekly Report (MMWR):* *Vital Signs*: Health Disparities in Hemodialysis-Associated *Staphylococcus aureus* Bloodstream Infections — United States, 2017–2020
Dialysis Safety
Core Interventions
Making Dialysis Safer for Patients Coalition
ESRD Network Organizations
Chronic Kidney Disease Initiative
Living with Diabetes
Sepsis
National Healthcare Safety Network
Nephrologists Transforming Dialysis Safetyemail_03Vital Signs Update	Get email updates about Vital Signs		Email Address			What's this?				Submit**VITAL SIGNS RESOURCES**
Digital Media Tools
							
					
			Last Updated Feb. 6, 2023														Source: 	Office of the Associate Director for Communication
					Facebook
        Twitter
        LinkedIn
        Syndicate homeVital Signs
Topics Covered
Digital Media Tools


About CDC
					Contact Us
					800-232-4636
 Facebook Twitter Instagram LinkedIn Youtube Pinterest Snapchat
 CONTACT CDC
				Contact Us
							Call 800-232-4636
							Email Us
			ABOUT CDC
				About CDC
							Jobs
							Funding
			POLICIES
				Accessibility
							External Links
							Privacy
							Policies
							No Fear Act
							FOIA
							OIG
							Nondiscrimination
							Vulnerability Disclosure Policy
			CONNECT WITH US
				Facebook
								Twitter
								Instagram
								LinkedIn
							Youtube
								Pinterest
								Snapchat
								Email
			LANGUAGES
				Español
							繁體中文
							Tiếng Việt
							한국어
							Tagalog
							Русский
							العربية
							Kreyòl Ayisyen
							Français
							Polski
							Português
							Italiano
							Deutsch
							日本語
							فارسی
							English


U.S. Department of Health & Human Services
			Accessibility
			External Links
			Privacy
			Policies
			No Fear Act
			FOIA
			Nondiscrimination
			OIG
			Vulnerability Disclosure Policy
			USA.gov


Exit Notification / Disclaimer Policy Close
 Links with this icon  indicate that you are leaving the CDC website. The Centers for Disease Control and Prevention (CDC) cannot attest to the accuracy of a non-federal website.
				Linking to a non-federal website does not constitute an endorsement by CDC or any of its employees of the sponsors or the information and products presented on the website.
				You will be subject to the destination website's privacy policy when you follow the link.
				CDC is not responsible for Section 508 compliance (accessibility) on other federal or private website. Website Disclaimers
 Cancel Continue